4//SEC Filing
FIBROGEN INC 4
Accession 0001209191-16-105765
$FGENCIK 0000921299operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:09 PM ET
Size
18.5 KB
Accession
0001209191-16-105765
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
VALONE FRANK H MD
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2016-03-01$3.92/sh+6,528$25,622→ 115,133 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-03-01−6,528→ 13,472 totalExercise: $3.92Exp: 2019-08-11→ Common Stock (6,528 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2016-03-01−2,508→ 5,000 totalExercise: $2.90Exp: 2020-06-09→ Common Stock (2,508 underlying) - Exercise/Conversion
Common Stock
2016-03-01$2.90/sh+2,508$7,273→ 117,641 total - Exercise/Conversion
Common Stock
2016-03-01$3.50/sh+1,714$5,999→ 119,355 total - Sale
Common Stock
2016-03-01$16.47/sh−7,260$119,579→ 112,095 total - Sale
Common Stock
2016-03-01$17.61/sh−3,490$61,461→ 108,605 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-03-01−1,714→ 30,028 totalExercise: $3.50Exp: 2021-06-07→ Common Stock (1,714 underlying)
Holdings
- 4,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices between $16.02 and $17.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The shares were sold at prices between $17.02 and $17.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Fully vested.
Documents
Issuer
FIBROGEN INC
CIK 0000921299
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000921299
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:09 PM ET
- Size
- 18.5 KB